2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$245.22-$2.63 (-1.06%)
Price as of Jun 23, 2026 7:54 PM EDT- $12.8BMarket Cap
- 143.83%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$245.22-$2.63 (-1.06%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $247.85 | ||
Change | -$2.65 (-1.06%) | ||
Open | $249.05 | ||
High | $253.00 | ||
Low | $245.94 | ||
Previous Close | $250.50 | ||
Volume | 814,132 | ||
30-Day Average Volume | 692,594 | ||
1-Week Change | -2.19% | ||
1-Month Change | 5.03% | ||
1-Year Change | 143.83% | ||
3-Year Change | 174.32% | ||
5-Year Change | 248.30% | ||
Fundamentals | |||
Shares Outstanding | 51.5M | ||
Total Assets | $713.6M | ||
Market Cap | $12.8B | ||
Enterprise Value | $12.6B | ||
Period: QTR TTM FY | |||
Revenue | $189.4M | ||
Net Income | -$64.5M | ||
Free Cash Flow | -$20.8M | ||
EBIT | -$61.5M | ||
EBITDA | -$59.9M | ||
Net Working Capital | $172.0M | ||
EPS | -$1.26 | ||
Enterprise Value/EBITDA | -211 | ||
Enterprise Value/Revenue | 67 | ||
P/B | 234 | ||
P/E | -197 | ||
PEG | 2 | ||
Price/Free Cash Flow | -613 | ||
Price/Operating Cash Flow | -616 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue